M
HZNP

MOTCO’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

MOTCO’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$116 – 818
2023
Q3 		$116 Sell
1
-18
-95% -$1.93K ﹤0.01% 782
2023
Q2 		$1.95K Buy
+19
New +$2K ﹤0.01% 656

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MOTCO's HZNP Position: Q4 2023 in Review

MOTCO sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1 share — an estimated $116 sold.

MOTCO first reported a position in HZNP in Q2 2023 and held it in 2 quarters. The position peaked at $1.95K in Q2 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • MOTCO reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • MOTCO sold 1 Horizon Therapeutics Public Limited Company Ordinary Shares share in Q4 2023, an estimated $116.
  • MOTCO first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2023 and held it in 2 quarters.
  • MOTCO's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.95K in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on MOTCO's 13F filing for Q4 2023, filed 9 Feb 2024.